Delivery Order SPE2DB22D2206-SPE2DB25FJP01
Award Date 8/21/25
Potential Completion Date 9/12/25
Potential Value $8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $9,584.58 to AmerisourceBergen Drug Corp for the supply of Trodelvy 180 mg vials under firm fixed price terms. The contract is non-competitive and was executed on August 8, 2025, with an ultimate completion date of August 29, 2025. AmerisourceBergen Drug Corp will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued against the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Trodelvy 180 mg vials with a ceiling value of $9,584.58. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency's Medical Supply Chain awarded a $9,584.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Trodelvy 180 mg vials, with an ultimate completion date of August 18, 2025. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $9,584.58 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Trodelvy 180 mg vials, with a completion deadline of September 5, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader relationship with the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trodelvy 180 mg vials with a contract value of $7,987.15. This is a firm fixed-price delivery order with a completion date of September 9, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation and will be performed at the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $9,584.58 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Trodelvy 180 mg vials. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This delivery order was competitively awarded without a set-aside...
- The Defense Logistics Agency awarded a $6,389.72 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trodelvy 180 mg vials, with an ultimate completion date of August 25, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Trodelvy 180 mg vials valued at $9,584.58. This is a firm fixed-price delivery order with no set-aside designation, to be completed by September 10, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $15,974.30 on August 25, 2025, for 180 mg vials of Trodelvy, a specialty oncology pharmaceutical. The contract is not set-aside and utilizes firm fixed pricing, with an ultimate completion date of September 16, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with the Defense...
- The Defense Logistics Agency awarded a $9,584.58 delivery order to AmerisourceBergen Drug Corp for the supply of Trodelvy 180 mg vials, with a completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order reflects the pharmaceutical distributor's ongoing role as a critical medical supplier to federal healthcare systems. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...